SCHEMBL6359436

SCHEMBL6359436

NN(Br)Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1472055 0.72
Phosphine SCHEMBL25307613 0.55
SCHEMBL11703522 0.55
SCHEMBL16634429 0.55
SCHEMBL10054281 0.50
SCHEMBL8149974 0.50
SCHEMBL7685267 0.50
SCHEMBL1682929 0.50
SCHEMBL874415 0.50
Ethylene SCHEMBL17700946 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1222171-A1 PYRIDINIUM DERIVATIVES FOR THE MANAGEMENT OF AGING-RELATED AND DIABETIC VASCULAR COMPLICATIONS, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF Torrent Pharmaceuticals Ltd (IN) 2002-07-17 EP claimed
WO-2001025208-A1 PYRIDINIUM DERIVATIVES FOR THE MANAGEMENT OF AGING-RELATED AND DIABETIC VASCULAR COMPLICATIONS, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF SANKARANARAYANAN ALANGUDI (IN) 2001-04-12 WO claimed
EP-0258968-A2 Treatment of iron-containing subterranean formations HALLIBURTON COMPANY (US) 1988-03-09 EP claimed
US-4683954-A ENHANCED OIL RECOVERY HALLIBURTON COMPANY (US) 1987-08-04 US claimed
CN-115667253-B Compounds useful for inhibiting RET kinase 伊莱利利公司 2025-06-17 CN disclosed
WO-2022172907-A1 METHOD FOR PROCESSING SUBSTRATE, AND METHOD FOR MANUFACTURING SILICON DEVICE COMPRISING SAID PROCESSING METHOD 株式会社トクヤマ 2022-08-18 WO disclosed
CN-1850755-A Method for preparing dibasic alcohol UNIV HUADONG TECHNOLOGY (CN) 2006-10-25 CN disclosed
US-20050065041-A1 GELLED ACID SCHLUMBERGER TECHNOLOGY CORPORATION (US) 2005-03-24 US disclosed
EP-1222171-A1 PYRIDINIUM DERIVATIVES FOR THE MANAGEMENT OF AGING-RELATED AND DIABETIC VASCULAR COMPLICATIONS, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF Torrent Pharmaceuticals Ltd (IN) 2002-07-17 EP disclosed
WO-2001025208-A1 PYRIDINIUM DERIVATIVES FOR THE MANAGEMENT OF AGING-RELATED AND DIABETIC VASCULAR COMPLICATIONS, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF SANKARANARAYANAN ALANGUDI (IN) 2001-04-12 WO disclosed
EP-0519639-A1 Viscosity reduction of downhole viscous fluids HALLIBURTON COMPANY (US) 1992-12-23 EP disclosed
US-5143157-A Activator for persulfate comprising a hydroxyacid or salt, hydroxylamine hydrochloride, gluconolactone or a copper compound using a polysaccharide gel thickener HALLIBURTON COMPANY (US) 1992-09-01 US disclosed
US-4997040-A Steel in subterranean wells BAKER HUGHES INCORPORATED (US) 1991-03-05 US disclosed
EP-0258968-A2 Treatment of iron-containing subterranean formations HALLIBURTON COMPANY (US) 1988-03-09 EP disclosed
US-4683954-A ENHANCED OIL RECOVERY HALLIBURTON COMPANY (US) 1987-08-04 US disclosed